top of page

Raising Awareness in Canine Cancer Awareness Month: Hemangiosarcoma Research and Hope

Among the various forms of canine cancer, hemangiosarcoma stands out as a particularly aggressive and challenging adversary. However, there is hope on the horizon.


a veterinarian looking after a big dog

Hemangiosarcoma: A Fierce Foe

Hemangiosarcoma, a malignant cancer that originates in the blood vessels, is an all-too-common diagnosis among our canine companions. Its stealthy nature often means it's only detected at an advanced stage, making it an even more formidable adversary. The statistics are alarming; it's estimated that hemangiosarcoma accounts for nearly 5% of all canine cancer cases.


This November, during Canine Cancer Awareness Month, it's crucial that we draw attention to this relentless disease, not only to raise awareness but also to highlight the encouraging strides made in research and potential treatments.


Immunotherapy: A Glimpse of Hope

Researchers are making significant headway in understanding hemangiosarcoma. Initial studies focusing on immunotherapy have suggested that canine hemangiosarcoma is immunogenic.


This is an exciting revelation, as it opens the door to new treatment strategies. Immunotherapy leverages the body's immune system to combat cancer cells, and this approach holds great promise for hemangiosarcoma treatment. By enhancing the immune response against the disease, researchers are aiming to improve the prognosis and quality of life for dogs diagnosed with this cancer.


Ongoing Studies: Paving the Way to Progress

Currently, several studies are underway to delve deeper into hemangiosarcoma, uncover potential treatment options, and move closer to a cure. A list of clinical trials can be found at https://www.hemangio.com/information/Clinical-Trials:

  1. A GD3 Nano-scaled Liposomal Cancer Vaccine Clinical Trial for Canine Hemangiosarcoma (Study ID: 03011): Researchers are testing a tiny, special vaccine for dogs with hemangiosarcoma. This vaccine aims to teach the dog's immune system to recognize and fight the cancer, potentially helping the dog's body to destroy cancer cells.

  2. Suppression of Extracellular Glutamate Efflux & mGluR1 Signaling to Impede Canine Hemangiosarcoma Cell Growth (Study ID: 03003): Scientists are studying ways to slow down or stop the growth of hemangiosarcoma cells. They're particularly looking at a molecule called glutamate and how it affects cancer cells. By understanding this, they hope to develop new treatments.

  3. Towards Curative Outcomes in Canine Hemangiosarcoma (Study ID: 02946): This study is all about finding ways to cure hemangiosarcoma in dogs. Researchers are trying to identify new therapies and treatments that could lead to better outcomes for dogs diagnosed with this cancer.

  4. Strategic Prevention of Canine Hemangiosarcoma: Lifetime Follow-Up (Study ID: 02806-MOU): Scientists are looking at how to prevent hemangiosarcoma in dogs. This includes following dogs throughout their lives to understand what might lead to this cancer. By understanding these risks, they hope to develop strategies to stop it from happening.

  5. Evaluation of Serum miRNA as a Diagnostic Tool for Canine Splenic Hemangiosarcoma (Study ID: 02746-A): This study focuses on finding better ways to diagnose hemangiosarcoma, particularly in the spleen. Scientists are exploring molecules called miRNA in the blood to see if they can act as early warning signs for this cancer.

  6. Clinical Trial for Evaluation of Propranolol and Doxorubicin in the Treatment of Canine Hemangiosarcoma (Study ID: 02534): Researchers are conducting a special trial to test if a drug called propranolol, combined with a common chemotherapy drug called doxorubicin, can effectively treat hemangiosarcoma in dogs. They want to see if this combination is more powerful against the cancer.

These studies aim to find better ways to treat, diagnose, and even prevent hemangiosarcoma in dogs. The hope is that this research will ultimately improve the lives of dogs and their families affected by this cancer.


These studies offer hope, not only for our beloved dogs but also for the countless families that have been affected by this disease. By participating in these research initiatives, we move closer to a future where hemangiosarcoma is no longer a devastating diagnosis.


a veterinarian checking a german shepherd

How You Can Help

As a pet owner or animal lover, there are several ways you can contribute to the cause during Canine Cancer Awareness Month:

  1. Spread Awareness: Share this information about Canine Cancer Awareness Month and the ongoing studies related to hemangiosarcoma. Awareness is the first step towards change.

  2. Support Research: Consider donating to organizations and research projects focused on hemangiosarcoma. Your contribution can make a significant difference.

  3. Educate Others: Encourage friends, family, and fellow pet owners to learn about the signs of cancer in dogs and the importance of early detection.

  4. Advocate for Regular Check-ups: Regular veterinary check-ups are vital. Encourage others to ensure their pets receive the best care, including cancer screenings.

In conclusion, Canine Cancer Awareness Month serves as a reminder of the challenges our furry friends face.


By supporting research and advocating for awareness, we take a significant step towards a future where canine cancer, including hemangiosarcoma, can be better understood, treated, and eventually prevented.


Hemangio.com is dedicated to making a difference in the lives of dogs and their families facing hemangiosarcoma. We are dedicated to driving awareness, providing educational resources, and supporting vital research initiatives. Through a community-oriented approach, we strive to improve the quality of life for dogs diagnosed with this aggressive form of cancer. Together, we can make a difference and bring hope to dogs and their families who are on the journey to combat canine cancer.


Comments


bottom of page